logo

Spero Therapeutics, Inc. (SPRO)



Trade SPRO now with
  Date
  Headline
5/3/2022 8:24:20 AM Spero Therapeutics Announces Immediate Cessation Of Tebipenem HBr Commercialization Initiatives; To Cut 75% Of Staff
1/19/2022 8:43:53 AM Spero Awarded Up To Addl $12.9 Mln By BARDA To Support Development Of Tebipenem Pivoxil In Pediatric Patients
1/4/2022 8:27:34 AM Spero Therapeutics Reports Lifting Of FDA Clinical Trial Hold On SPR720
7/5/2021 6:06:48 AM Spero Therapeutics Enters Licensing Agreement With Pfizer For SPR206 In Ex-U.S. And Ex-Asia Territories
2/5/2021 8:19:20 AM Spero Therapeutics Says FDA Placed Clinical Hold On Phase 2a Clinical Trial Of SPR720
3/6/2014 4:47:32 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.015 , Record Date 3/21/2014
3/8/2012 5:10:54 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.0125, Record Date 3/22/2012
8/9/2011 4:54:56 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.0125, Record Date 9/16/2011
11/9/2010 5:05:48 PM SmartPros Ltd. (SPRO) Announces $750K Stock Buyback
11/9/2010 5:04:43 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.01, Record Date 12/15/2010